ESTRO 2024 - Abstract Book

S1989

Clinical - Mixed sites, palliation

ESTRO 2024

example co-morbidities or alternative treatment modality availability (e.g. surgery). We demonstrate that for every 100 tumours diagnosed in England in 2020, 38.2 tumours underwent radiotherapy. This number is slightly lower than the demand models suggest is optimal, but it is unclear if the covid-19 pandemic may have impacted on radiotherapy utilisation in this period. Importantly, variation in utilisation is seen across the country. Further work is now required to consider the possible impact of covid-19, assess utilisation of palliative radiotherapy, better understand radiotherapy utilisation across different cancer sites and demographic groups and, in parallel, examine the causes of observed geographical variation. These analyses can then inform future radiotherapy policy at both national and regional levels.

Keywords: Utilisation, Health services, Radiotherapy

References:

1. Borras JM, Lievens Y, Dunscombe P, Coffey M, Malicki J, Corral J, et al. The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis. Radiotherapy and Oncology. 2015 Jul 1;116(1):38 – 44. 2. Mee T, Kirkby NF, Defourny NN, Kirkby KJ, Burnet NG. The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project. Br J Radiol. 2023 Oct 9;20230334.

3. Round CE, Williams MV, Mee T, Kirkby NF, Cooper T, Hoskin P, et al. Radiotherapy Demand and Activity in England 2006 – 2020. Clinical Oncology. 2013 Sep;25(9):522 – 30.

4. Jena R, Round C, Mee T, Kirkby N, Hoskin P, Williams M. The Malthus programme--a new tool for estimating radiotherapy demand at a local level. Clinical oncology. 2012 Feb;24(1):1 – 3.

5. Sandhu S, Sharpe M, Findlay Ú, Roe C, Broggio J, Spencer K, et al. Cohort profile: radiotherapy dataset (RTDS) in England. BMJ Open. 2023 Jun;13(6):e070699.

6. Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, et al. Data Resource Profile: National Cancer Registration Dataset in England. International Journal of Epidemiology. 2020 Feb 1;49(1):16 – 16h.

7.

NHS England » Integrated care boards in England [Internet]. [cited 2023 Oct 15]. Available from:

https://www.england.nhs.uk/publication/integrated-care-boards-in-england/

8. Borras JM, Barton M, Grau C, Corral J, Verhoeven R, Lemmens V, et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project. Radiotherapy and Oncology. 2015 Jul 1;116(1):45 – 50. Barton MB, Jacob S, Shafiq J, Wong K, Thompson SR, Hanna TP, et al. Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012. Radiotherapy and Oncology. 2014 Jul;112(1):140 – 4. 9.

10. Jena R. Quantifying Uncertainty in Radiotherapy Demand at the Local and National Level using the Malthus Model. Clinical Oncology. 2015;7.